Tel Aviv, Israel – December 4th, 2020
MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today –the multi-year partnership with FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging solutions, to commercialize the Accipio Clinical Platform.
The Accipio Clinical Platform generates multiple insights into a patient’s medical imaging study that may provide a faster and clinically accurate diagnosis of Intracranial Hemorrhage (ICH) in acute care settings across the globe. The platform is comprised of Accipio Ix (Intracranial Hemorrhage (ICH) triage and notification, Accipio Ax (Slice-Level Annotation), and Accipio Dxg (Triage for ICH Presence or Absence)**.
MaxQ is the only AI platform company offering advanced AI applications and AI platform solutions, such as MaxQ Xpress, as a seamless, integrated offering, secured through ISO 27001 and ISO 27799 cybersecurity standards. When launched through Fujifilm’s Synapse PACS platform, which ranks among the fastest and most secure enterprise imaging solutions in the industry—the Accipio and Synapse seamless solution deliver deep clinical and actionable insights, enabling clinicians to make faster assessments of patients.
“At MaxQ, our goal is to equip physicians with AI-based solutions that enable them to deliver faster, more confident patient care, while reducing costs, and physician workload,” says Michael Rosenberg, Chief Executive Officer of MaxQ AI. “We’ve worked extensively with Fujifilm over the last year on our first deployment at Capital Health Hospitals in New Jersey. In collaboration with FujiFilm and the wonderful staff at Capital Health Hospital, our teams have successfully integrated Accipio into Fujifilm’s Synapse PACS, achieving a seamless clinical workflow enhanced with deep clinical AI.”
About MaxQ AI, Ltd.
MaxQ AI is transforming healthcare by empowering physicians to provide ‘smarter care’ with enhanced clinical workflow solutions assisting with improved patient triage and artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel and Andover, MA our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing intracranial hemorrhage, stroke, brain trauma, and other serious conditions. To learn more, visit www.maxq.ai or follow us on LinkedIn.
For MaxQ AI:
*References Available Upon Request
**MaxQ Device Regulatory Status Available at www.maxq.ai